5Piddock LJV. New quinolones and gram-positive bacteria[J ].Anitimicrob Agents Chemiother, 1994, 38:163.
6Watanabe K, Kato N, Muto Y. In vitro activities of a new quinolone, sparfloxacin against anaerobic bacteria [ J ]. Chemotherapy, 1991, 39:117.
7Ricart P. Sparfloxacin and other quinolones [ J ]. Antimicrob Chemother, 1992, 30(6) :739.
8Henry D, Elliso W, Sullivan J, et al. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxiacin[J ]. Antimicrob Agents Chemother, 1998, 42 (9) :2262.
9Nakamura S, Minami A, Nakata K, et al. In vitro and in vivo antibacterial activites of AT-4140, a new broad-spectrum quinolone[J ]. Antimicrob Agents Chemother, 1989, 33 : 1167.
10Philips I, Dimian C, Barlow D, et al. A comparative study of two different regimens of sparfloxacin versus doxycycline in the treatment of nongonococcal urethritis in men[J ]. J Antimicrob Chemother, 1996, 37 : 123.
